• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳性选择和阴性选择塑造了人类初始 B 细胞库。

Positive and negative selection shape the human naive B cell repertoire.

机构信息

Department of Immunobiology, Yale University, New Haven, Connecticut, USA.

Department of Medicine, Section of Rheumatology, Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Illinois, USA.

出版信息

J Clin Invest. 2022 Jan 18;132(2). doi: 10.1172/JCI150985.

DOI:10.1172/JCI150985
PMID:34813502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8759783/
Abstract

Although negative selection of developing B cells in the periphery is well described, yet poorly understood, evidence of naive B cell positive selection remains elusive. Using 2 humanized mouse models, we demonstrate that there was strong skewing of the expressed immunoglobulin repertoire upon transit into the peripheral naive B cell pool. This positive selection of expanded naive B cells in humanized mice resembled that observed in healthy human donors and was independent of autologous thymic tissue. In contrast, negative selection of autoreactive B cells required thymus-derived Tregs and MHC class II-restricted self-antigen presentation by B cells. Indeed, both defective MHC class II expression on B cells of patients with rare bare lymphocyte syndrome and prevention of self-antigen presentation via HLA-DM inhibition in humanized mice resulted in the production of autoreactive naive B cells. These latter observations suggest that Tregs repressed autoreactive naive B cells continuously produced by the bone marrow. Thus, a model emerged, in which both positive and negative selection shaped the human naive B cell repertoire and that each process was mediated by fundamentally different molecular and cellular mechanisms.

摘要

尽管外周发育中的 B 细胞的负选择已得到很好的描述,但仍知之甚少,而幼稚 B 细胞的正选择的证据仍然难以捉摸。使用 2 种人源化小鼠模型,我们证明在进入外周幼稚 B 细胞库时,表达的免疫球蛋白库发生了强烈的偏倚。这种在人源化小鼠中扩增的幼稚 B 细胞的正选择类似于在健康的人类供体中观察到的情况,并且独立于自体胸腺组织。相比之下,自身反应性 B 细胞的负选择需要来自胸腺的 Treg 和由 B 细胞呈递的 MHC Ⅱ类限制的自身抗原。事实上,在罕见的裸淋巴细胞综合征患者的 B 细胞中 MHC Ⅱ类表达缺陷,以及通过在人源化小鼠中抑制 HLA-DM 来防止自身抗原呈递,均导致产生了自身反应性幼稚 B 细胞。这些后一种观察结果表明,Treg 持续抑制骨髓中不断产生的自身反应性幼稚 B 细胞。因此,出现了一种模型,其中正选择和负选择共同塑造了人类幼稚 B 细胞库,并且每个过程都由根本不同的分子和细胞机制介导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/5f3ea892b7f3/jci-132-150985-g142.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/94ec61117db8/jci-132-150985-g136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/c722b0ea7196/jci-132-150985-g137.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/5236ef9ca568/jci-132-150985-g138.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/c7c41ec7c04e/jci-132-150985-g139.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/cd9f09219215/jci-132-150985-g140.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/a40deb471e32/jci-132-150985-g141.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/5f3ea892b7f3/jci-132-150985-g142.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/94ec61117db8/jci-132-150985-g136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/c722b0ea7196/jci-132-150985-g137.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/5236ef9ca568/jci-132-150985-g138.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/c7c41ec7c04e/jci-132-150985-g139.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/cd9f09219215/jci-132-150985-g140.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/a40deb471e32/jci-132-150985-g141.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/8759783/5f3ea892b7f3/jci-132-150985-g142.jpg

相似文献

1
Positive and negative selection shape the human naive B cell repertoire.阳性选择和阴性选择塑造了人类初始 B 细胞库。
J Clin Invest. 2022 Jan 18;132(2). doi: 10.1172/JCI150985.
2
MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4 T cells.主要组织相容性复合体II类(MHC-II)等位基因塑造了传统型和调节型初始CD4 T细胞的互补决定区3(CDR3)库。
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13659-13669. doi: 10.1073/pnas.2003170117. Epub 2020 Jun 1.
3
Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.用于体内诱导CD4+T细胞耐受性的自身肽的呈递受一个定位在主要组织相容性复合体基因座II类区域的加工因子调控。
J Exp Med. 1995 Nov 1;182(5):1481-91. doi: 10.1084/jem.182.5.1481.
4
MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.主要组织相容性复合体(MHC)不匹配的混合嵌合体介导交叉反应性自身反应性T细胞的胸腺清除,并预防非肥胖糖尿病小鼠的胰岛炎。
J Immunol. 2015 Jan 1;194(1):407-17. doi: 10.4049/jimmunol.1401584. Epub 2014 Nov 26.
5
Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines.DM阴性B细胞系对大量内源性II类DR限制性抗原的呈递
Eur J Immunol. 1997 Apr;27(4):1014-21. doi: 10.1002/eji.1830270431.
6
Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells.在人源化 NOD.Rag1KO.IL2RgcKO 小鼠中,HLA Ⅱ类分子的表达对于人 T 和 B 细胞的发育和功能至关重要。
PLoS One. 2011;6(5):e19826. doi: 10.1371/journal.pone.0019826. Epub 2011 May 17.
7
A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity.一种新的 II 类 MHC 分子呈递途径,涉及自身免疫中重要的肽或变性蛋白。
Mol Immunol. 2013 Sep;55(2):166-8. doi: 10.1016/j.molimm.2012.10.024. Epub 2012 Nov 27.
8
Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.靶向调节自身肽呈递可预防小鼠 I 型糖尿病而不破坏一般免疫能力。
J Clin Invest. 2010 Apr;120(4):1324-36. doi: 10.1172/JCI40220.
9
GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.GILT 在胸腺上皮细胞中促进了对组织受限的、与黑色素瘤相关的自身抗原的中枢 CD4 T 细胞耐受。
J Immunol. 2020 Jun 1;204(11):2877-2886. doi: 10.4049/jimmunol.1900523. Epub 2020 Apr 8.
10
Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance Induction.胸腺 B 细胞被许可呈递自身抗原以诱导中枢 T 细胞耐受。
Immunity. 2015 Jun 16;42(6):1048-61. doi: 10.1016/j.immuni.2015.05.013. Epub 2015 Jun 9.

引用本文的文献

1
A Room for Long-Lived Plasma Cell Contribution in Immune Cytopenias?长寿浆细胞在免疫性血细胞减少症中的作用空间?
Cancers (Basel). 2025 May 1;17(9):1537. doi: 10.3390/cancers17091537.
2
Self-reactive B cells are increased in all major stages of peripheral development in Sjögren's disease.在干燥综合征外周发育的所有主要阶段,自身反应性B细胞均增多。
Immunol Cell Biol. 2025 Apr;103(4):401-410. doi: 10.1111/imcb.70005. Epub 2025 Feb 17.
3
Immune Tolerance Regulation Is Critical to Immune Homeostasis.免疫耐受调节对免疫稳态至关重要。

本文引用的文献

1
Autoreactivity in naïve human fetal B cells is associated with commensal bacteria recognition.未成熟人胎儿 B 细胞中的自身反应性与共生菌识别有关。
Science. 2020 Jul 17;369(6501):320-325. doi: 10.1126/science.aay9733.
2
Impaired ATM activation in B cells is associated with bone resorption in rheumatoid arthritis.B 细胞中 ATM 激活受损与类风湿关节炎中的骨吸收有关。
Sci Transl Med. 2019 Nov 20;11(519). doi: 10.1126/scitranslmed.aaw4626.
3
Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.
J Immunol Res. 2025 Jan 7;2025:5006201. doi: 10.1155/jimr/5006201. eCollection 2025.
4
Senolytic Vaccines from the Central and Peripheral Tolerance Perspective.从中枢和外周耐受角度看衰老细胞溶解疫苗
Vaccines (Basel). 2024 Dec 10;12(12):1389. doi: 10.3390/vaccines12121389.
5
T Cell Development and Responses in Human Immune System Mice.人类免疫系统小鼠中的T细胞发育与反应
Annu Rev Immunol. 2025 Apr;43(1):83-112. doi: 10.1146/annurev-immunol-082223-041615. Epub 2024 Dec 20.
6
Molecular mimicry as a mechanism of viral immune evasion and autoimmunity.分子模拟作为病毒免疫逃逸和自身免疫的一种机制。
Nat Commun. 2024 Oct 30;15(1):9403. doi: 10.1038/s41467-024-53658-8.
7
B cell tolerance and autoimmunity: Lessons from repertoires.B 细胞耐受与自身免疫:从库中得到的启示。
J Exp Med. 2024 Sep 2;221(9). doi: 10.1084/jem.20231314. Epub 2024 Aug 2.
8
Targeted therapy for multiple myeloma: an overview on CD138-based strategies.多发性骨髓瘤的靶向治疗:基于CD138策略的概述
Front Oncol. 2024 Apr 9;14:1370854. doi: 10.3389/fonc.2024.1370854. eCollection 2024.
9
Molecular Mimicry as a Mechanism of Viral Immune Evasion and Autoimmunity.分子模拟作为病毒免疫逃逸和自身免疫的一种机制。
bioRxiv. 2024 Mar 9:2024.03.08.583134. doi: 10.1101/2024.03.08.583134.
10
B cell development and antibody responses in human immune system mice: current status and future perspective.人源化免疫系统小鼠中的 B 细胞发育和抗体反应:现状和未来展望。
Sci China Life Sci. 2024 Apr;67(4):645-652. doi: 10.1007/s11427-023-2462-8. Epub 2024 Jan 15.
B 细胞耐受检查点受损会促进自身免疫性疾病和致病性自身抗体的产生。
Immunol Rev. 2019 Nov;292(1):90-101. doi: 10.1111/imr.12821. Epub 2019 Nov 12.
4
B cell superantigens in the human intestinal microbiota.人类肠道微生物群中的 B 细胞超抗原。
Sci Transl Med. 2019 Aug 28;11(507). doi: 10.1126/scitranslmed.aau9356.
5
Persisting enteropathy and disturbed adaptive mucosal immunity due to MHC class II deficiency.由于 MHC II 类缺陷导致的持续性肠病和适应性黏膜免疫紊乱。
Clin Immunol. 2019 Jun;203:125-133. doi: 10.1016/j.clim.2019.04.012. Epub 2019 Apr 24.
6
AIRE expression controls the peripheral selection of autoreactive B cells.AIRE 表达控制自身反应性 B 细胞的外周选择。
Sci Immunol. 2019 Apr 12;4(34). doi: 10.1126/sciimmunol.aav6778.
7
Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells.Tcf1 和 Lef1 对于调节性 T 细胞的免疫抑制功能是必需的。
J Exp Med. 2019 Apr 1;216(4):847-866. doi: 10.1084/jem.20182010. Epub 2019 Mar 5.
8
Mechanisms of central tolerance for B cells.B细胞中枢耐受的机制。
Nat Rev Immunol. 2017 May;17(5):281-294. doi: 10.1038/nri.2017.19. Epub 2017 Apr 3.
9
Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome.双向移植物内同种异体反应性驱动人肠道同种异体移植物的再填充,并与临床结果相关。
Sci Immunol. 2016 Oct;1(4). doi: 10.1126/sciimmunol.aah3732. Epub 2016 Oct 7.
10
BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell Tolerance.BCR和内体Toll样受体信号协同作用以增加AID表达并建立中枢B细胞耐受性。
Cell Rep. 2017 Feb 14;18(7):1627-1635. doi: 10.1016/j.celrep.2017.01.050.